Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
L. C. Wellinger, S. J. Hogg, D. M. Newman…·R. W. Johnstone
This paper identifies BET bromodomain inhibitors as agents that enhance anti-tumor immunity by sensitizing tumors to TNF-mediated cytotoxicity through suppression of NF-κB signaling.
J. Salmon, I. Todorovski, S. J. Vervoort…·R. W. Johnstone
The paper shows that inhibiting HDACs in AML promotes type I IFN production by pDCs, enhancing anti-tumor immunity and therapeutic benefit.
S. Nüssing, I. G. House, C. J. Kearney…·I. A. Parish
This paper demonstrates efficient CRISPR/Cas9 gene ablation in uncultured naive mouse T cells for in vivo studies, showing gene deletion occurs independently of T cell activation.